Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor
about
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownRecent advances in vaccine development for herpes simplex virus types I and IIDiversity in CD8(+) T cell function and epitope breadth among persons with genital herpes.Diversity in the acute CD8 T cell response to vaccinia virus in humans.Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesAltered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.Current status and prospects for development of an HSV vaccineExpression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.Homing in on the cellular immune response to HSV-2 in humans.T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection.Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgeniCD8+ TCR Bias and Immunodominance in HIV-1 Infection.Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individualsDiscovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.Reverse vaccinology: developing vaccines in the era of genomicsDeveloping an asymptomatic mucosal herpes vaccine: the present and the future.A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensVirus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.Prospects for developing an effective vaccine against ocular herpes simplex virus infection.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.The challenge of developing a herpes simplex virus 2 vaccine.Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.Asymptomatic memory CD8+ T cells: from development and regulation to consideration for human vaccines and immunotherapeuticsT-cell immunity to human alphaherpesviruses.A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infectionHerpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infectionA Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And Characterization.Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells.An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance.
P2860
Q21296712-122F9BB7-3E15-49DD-B614-1DF305A0B9D3Q26859623-731CC967-BA30-49FF-B8CE-9CFCB72FC96DQ30496837-F5344A9C-A013-4A5E-8344-B5323FF428E8Q33227607-0BA55F4F-DC79-429F-850D-3BA52D02FDCBQ33248961-CF21E8AE-5F7B-4206-9242-04A27BBFBDFFQ33754153-5D96621C-B22D-491F-94CA-001AFC742B66Q33824488-4D25EDC4-61BB-4846-B5E2-D695F9BF4955Q33931016-A773E3B1-051D-47DF-A7B1-3DFBBF9890F1Q34081662-F5F7E102-D8B5-43D9-A377-D6E06C4CE36AQ34081670-72B4124C-FF4E-463D-B9F0-1BACFFE60A72Q34575622-308C94FB-8361-4B4B-AF4D-F579B1EC1F26Q34648449-AB7FD7FF-C65E-4CC6-8C42-A8F62D529AFAQ35122383-F28F7DFB-40D4-4345-BAA9-26A6254B50A1Q35613273-108ECAE3-3021-438C-94E8-C800116F6DFBQ35699002-67D429A4-46A4-48F8-AC19-9D88C62F7A43Q35868029-BEE37C87-FE26-45C0-9E23-0AEA5DEAF3F1Q35868054-CB32FE73-23E8-4C3D-88F1-8F54950269E4Q35873940-9C5C6648-AD87-433F-B2C5-5D84B390B6FFQ35881975-B4799CC1-A61D-48FF-A1FD-CFCFE1203D37Q35914367-DBDD3D52-9FFE-4156-856B-33972A8688ECQ36267182-2ADDC550-E598-404F-9ED3-C25D4CE98100Q36311038-B15D2A90-C6B9-4CDE-A7B2-E294AF01DE00Q36555158-E005D017-90BA-45CB-842A-79B6F96915BFQ36671106-FCF008E1-8D62-4D59-AA40-B8D8EB494B4BQ36871818-BC7E0229-E584-40AA-9FCF-3E73CCF84B99Q36977847-C4B30182-D20A-4C9B-86A6-1C22467CC824Q37107189-24BC8234-8BA9-4AB2-A454-A342150F30C6Q37118262-8D10FD1C-B52D-47CC-A127-4FD38F7E95E0Q37127506-E919D6E8-8179-4F28-BFF8-5FCD7B0E8293Q37174520-6DD079D1-9686-4CDE-82DA-0059CE93626AQ37253436-A95EBD16-B260-4A5F-AC42-B0B309549A21Q37679220-30DC9FE9-FEAE-4E7F-BB6C-DB7E0B7C3830Q37963480-873C83EC-4139-46ED-A41A-3506B4B7DC44Q38682076-DBF570A1-5A59-4CEC-84A5-B4B39827ED0FQ39764626-77FC6F5C-C443-47E0-B2D3-FE02090DF29FQ40121437-2D6119E8-96F0-4A4C-9E9E-D4C6008ED2DAQ42282904-3D3080A3-2358-4A70-9AE3-2DFBA218ECB1Q42938727-4E6FB7B7-E800-435A-AA6F-D363EBB5EE0A
P2860
Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Immunodominance among herpes s ...... issue-specific homing receptor
@ast
Immunodominance among herpes s ...... issue-specific homing receptor
@en
type
label
Immunodominance among herpes s ...... issue-specific homing receptor
@ast
Immunodominance among herpes s ...... issue-specific homing receptor
@en
prefLabel
Immunodominance among herpes s ...... issue-specific homing receptor
@ast
Immunodominance among herpes s ...... issue-specific homing receptor
@en
P2093
P2860
P50
P356
P1476
Immunodominance among herpes s ...... issue-specific homing receptor
@en
P2093
Christopher L McClurkan
Clement A Meseda
Devon C Snow
Jeffrey Vieira
Nancy A Hosken
Randal C Cevallos
P2860
P304
12899-12904
P356
10.1073/PNAS.2131705100
P407
P577
2003-10-17T00:00:00Z